Literature DB >> 12815589

Clear relationship between ETF/ETFDH genotype and phenotype in patients with multiple acyl-CoA dehydrogenation deficiency.

Rikke K J Olsen1, Brage S Andresen, Ernst Christensen, Peter Bross, Flemming Skovby, Niels Gregersen.   

Abstract

Mutations in electron transfer flavoprotein (ETF) and its dehydrogenase (ETFDH) are the molecular basis of multiple acyl-CoA dehydrogenation deficiency (MADD), an autosomal recessively inherited and clinically heterogeneous disease that has been divided into three clinical forms: a neonatal-onset form with congenital anomalies (type I), a neonatal-onset form without congenital anomalies (type II), and a late-onset form (type III). To examine whether these different clinical forms could be explained by different ETF/ETFDH mutations that result in different levels of residual ETF/ETFDH enzyme activity, we have investigated the molecular genetic basis for disease development in nine patients representing the phenotypic spectrum of MADD. We report the genomic structures of the ETFA, ETFB, and ETFDH genes and the identification and characterization of seven novel and three previously reported disease-causing mutations. Our molecular genetic investigations of these nine patients are consistent with three clinical forms of MADD showing a clear relationship between the nature of the mutations and the severity of disease. Interestingly, our data suggest that homozygosity for two null mutations causes fetal development of congenital anomalies resulting in a type I disease phenotype. Even minute amounts of residual ETF/ETFDH activity seem to be sufficient to prevent embryonic development of congenital anomalies giving rise to type II disease. Overexpression studies of an ETFB-D128N missense mutation identified in a patient with type III disease showed that the residual activity of the mutant enzyme could be rescued up to 59% of that of wild-type activity when ETFB-D128N-transformed E. coli cells were grown at low temperature. This indicates that the effect of the ETF/ETFDH genotype in patients with milder forms of MADD, in whom residual enzyme activity allows modulation of the enzymatic phenotype, may be influenced by environmental factors like cellular temperature. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12815589     DOI: 10.1002/humu.10226

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  67 in total

1.  The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation.

Authors:  Stefan Kölker; Angeles Garcia-Cazorla; Angeles Garcia Cazorla; Vassili Valayannopoulos; Allan M Lund; Alberto B Burlina; Jolanta Sykut-Cegielska; Frits A Wijburg; Elisa Leão Teles; Jiri Zeman; Carlo Dionisi-Vici; Ivo Barić; Daniela Karall; Persephone Augoustides-Savvopoulou; Lise Aksglaede; Jean-Baptiste Arnoux; Paula Avram; Matthias R Baumgartner; Javier Blasco-Alonso; Brigitte Chabrol; Anupam Chakrapani; Kimberly Chapman; Elisenda Cortès I Saladelafont; Maria L Couce; Linda de Meirleir; Dries Dobbelaere; Veronika Dvorakova; Francesca Furlan; Florian Gleich; Wanda Gradowska; Stephanie Grünewald; Anil Jalan; Johannes Häberle; Gisela Haege; Robin Lachmann; Alexander Laemmle; Eveline Langereis; Pascale de Lonlay; Diego Martinelli; Shirou Matsumoto; Chris Mühlhausen; Hélène Ogier de Baulny; Carlos Ortez; Luis Peña-Quintana; Danijela Petković Ramadža; Esmeralda Rodrigues; Sabine Scholl-Bürgi; Etienne Sokal; Christian Staufner; Marshall L Summar; Nicholas Thompson; Roshni Vara; Inmaculada Vives Pinera; John H Walter; Monique Williams; Peter Burgard
Journal:  J Inherit Metab Dis       Date:  2015-04-15       Impact factor: 4.982

Review 2.  Delineating the role of alterations in lipid metabolism to the pathogenesis of inherited skeletal and cardiac muscle disorders: Thematic Review Series: Genetics of Human Lipid Diseases.

Authors:  Harjot K Saini-Chohan; Ryan W Mitchell; Frédéric M Vaz; Teresa Zelinski; Grant M Hatch
Journal:  J Lipid Res       Date:  2011-11-07       Impact factor: 5.922

Review 3.  Lipid storage myopathy.

Authors:  Wen-Chen Liang; Ichizo Nishino
Journal:  Curr Neurol Neurosci Rep       Date:  2011-02       Impact factor: 5.081

4.  Disease mechanisms and protein structures in fatty acid oxidation defects.

Authors:  Niels Gregersen; Rikke K J Olsen
Journal:  J Inherit Metab Dis       Date:  2010-02-12       Impact factor: 4.982

5.  Clinical features and ETFDH mutation spectrum in a cohort of 90 Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency.

Authors:  Jianying Xi; Bing Wen; Jie Lin; Wenhua Zhu; Sushan Luo; Chongbo Zhao; Duoling Li; Pengfei Lin; Jiahong Lu; Chuanzhu Yan
Journal:  J Inherit Metab Dis       Date:  2013-12-20       Impact factor: 4.982

6.  Molecular analysis of 51 unrelated pedigrees with late-onset multiple acyl-CoA dehydrogenation deficiency (MADD) in southern China confirmed the most common ETFDH mutation and high carrier frequency of c.250G>A.

Authors:  Zhi-Qiang Wang; Xue-Jiao Chen; Shen-Xing Murong; Ning Wang; Zhi-Ying Wu
Journal:  J Mol Med (Berl)       Date:  2011-02-24       Impact factor: 4.599

Review 7.  Riboflavin-responsive multiple Acyl-CoA dehydrogenation deficiency in 13 cases, and a literature review in mainland Chinese patients.

Authors:  Min Zhu; Xuan Zhu; Xueliang Qi; Ding Weijiang; Yajing Yu; Hui Wan; Daojun Hong
Journal:  J Hum Genet       Date:  2014-02-13       Impact factor: 3.172

8.  Characterizing the transcriptional regulation of let-721, a Caenorhabditis elegans homolog of human electron flavoprotein dehydrogenase.

Authors:  Derek S Chew; Allan K Mah; David L Baillie
Journal:  Mol Genet Genomics       Date:  2009-09-23       Impact factor: 3.291

9.  Loss of Pink1 modulates synaptic mitochondrial bioenergetics in the rat striatum prior to motor symptoms: concomitant complex I respiratory defects and increased complex II-mediated respiration.

Authors:  Kelly L Stauch; Lance M Villeneuve; Phillip R Purnell; Brendan M Ottemann; Katy Emanuel; Howard S Fox
Journal:  Proteomics Clin Appl       Date:  2016-09-21       Impact factor: 3.494

10.  Newborn Screening for Glutaric Aciduria-II: The New England Experience.

Authors:  I Sahai; C L Garganta; J Bailey; P James; H L Levy; M Martin; E Neilan; C Phornphutkul; D A Sweetser; T H Zytkovicz; R B Eaton
Journal:  JIMD Rep       Date:  2013-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.